265 related articles for article (PubMed ID: 28079013)
1. Natural Product Inhibitors of Topoisomerases: Review and Docking Study.
Scotti L; Bezerra Mendonca FJ; Ribeiro FF; Tavares JF; da Silva MS; Barbosa Filho JM; Scotti MT
Curr Protein Pept Sci; 2018; 19(3):275-291. PubMed ID: 28079013
[TBL] [Abstract][Full Text] [Related]
2. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation.
Singh S; Das T; Awasthi M; Pandey VP; Pandey B; Dwivedi UN
Biotechnol Appl Biochem; 2016; 63(1):125-37. PubMed ID: 25594242
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
Kathiravan MK; Kale AN; Nilewar S
Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
[TBL] [Abstract][Full Text] [Related]
5. DNA topoisomerases as molecular targets for anticancer drugs.
Buzun K; Bielawska A; Bielawski K; Gornowicz A
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1781-1799. PubMed ID: 32975138
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Liang X; Wu Q; Luan S; Yin Z; He C; Yin L; Zou Y; Yuan Z; Li L; Song X; He M; Lv C; Zhang W
Eur J Med Chem; 2019 Jun; 171():129-168. PubMed ID: 30917303
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
8. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
[TBL] [Abstract][Full Text] [Related]
9. DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives.
Garro HA; Pungitore CR
Curr Drug Targets; 2019; 20(1):70-80. PubMed ID: 29697027
[TBL] [Abstract][Full Text] [Related]
10. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
Menezes JCJMDS; Diederich MF
Eur J Med Chem; 2019 Nov; 182():111637. PubMed ID: 31494471
[TBL] [Abstract][Full Text] [Related]
11. Natural products as antiparasitic drugs.
Kayser O; Kiderlen AF; Croft SL
Parasitol Res; 2003 Jun; 90 Suppl 2():S55-62. PubMed ID: 12937967
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids acting on DNA topoisomerases: recent advances and future perspectives in cancer therapy.
Russo P; Del Bufalo A; Cesario A
Curr Med Chem; 2012; 19(31):5287-93. PubMed ID: 22998568
[TBL] [Abstract][Full Text] [Related]
14. DNA binding and Topoisomerase inhibition: How can these mechanisms be explored to design more specific anticancer agents?
de Almeida SMV; Ribeiro AG; de Lima Silva GC; Ferreira Alves JE; Beltrão EIC; de Oliveira JF; de Carvalho LB; Alves de Lima MDC
Biomed Pharmacother; 2017 Dec; 96():1538-1556. PubMed ID: 29174576
[TBL] [Abstract][Full Text] [Related]
15. Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids.
Nwodo JN; Ibezim A; Simoben CV; Ntie-Kang F
Anticancer Agents Med Chem; 2016; 16(1):108-27. PubMed ID: 25991425
[TBL] [Abstract][Full Text] [Related]
16. Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products.
Xin LT; Liu L; Shao CL; Yu RL; Chen FL; Yue SJ; Wang M; Guo ZL; Fan YC; Guan HS; Wang CY
Mar Drugs; 2017 Jul; 15(7):. PubMed ID: 28698495
[TBL] [Abstract][Full Text] [Related]
17. Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2017 Nov; 35(14):3082-3097. PubMed ID: 27667581
[TBL] [Abstract][Full Text] [Related]
18. New insights for the use of quercetin analogs in cancer treatment.
Iacopetta D; Grande F; Caruso A; Mordocco RA; Plutino MR; Scrivano L; Ceramella J; Muià N; Saturnino C; Puoci F; Rosano C; Sinicropi MS
Future Med Chem; 2017 Nov; 9(17):2011-2028. PubMed ID: 29076772
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems.
Dehshahri A; Ashrafizadeh M; Ghasemipour Afshar E; Pardakhty A; Mandegary A; Mohammadinejad R; Sethi G
Pharmacol Res; 2020 Jan; 151():104551. PubMed ID: 31743776
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
